Curriculum · Public Health and Communicable Diseases
Initiating antiretroviral therapy in HIV
What it is
Who to treat in HIV is everyone. The decision does not wait on a number, so a patient found on testing to have HIV antibody is a patient for antiretroviral therapy.
How it is treated
What to start is one of two:
- 2 NRTIs plus an integrase inhibitor.
- 2 NRTIs plus a PI.
NRTI is the nucleoside reverse transcriptase inhibitor class, and the third drug is either the integrase inhibitor or the PI. Prevention runs alongside the antiretroviral therapy itself: patients with HIV require prophylaxis to prevent Pneumocystis jirovecii pneumonia with CD4 counts <200/mm3, the drug being TMP-SMX, and antiretrovirals in HIV are themselves listed under prevention of that pneumonia.